Citations (213)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (32)
Ann Childress, Robert Sottile & Sherine Khanbijian. (2023) Viloxazine extended-release capsules for the treatment of attention-deficit/ hyperactivity disorder in adult patients. Expert Review of Neurotherapeutics 23:11, pages 945-953.
Read now
Read now
Elizabeth A. Barnhardt, Anita R. Narayanan & Daniel L. Coury. (2023) Evaluating serdexmethylphenidate and dexmethylphenidate capsules as a once-daily treatment option for ADHD. Expert Opinion on Pharmacotherapy 24:11, pages 1215-1219.
Read now
Read now
Mustafa Tuncturk, Cagatay Ermis, Dicle Buyuktaskin, Eren Halac, Ekin Sut, Oben Ozkan, Nazan Gundogan, Guldal Unutmaz, R. Ogulcan Ciray, Serkan Turan & Aynur Akay Pekcanlar. (2023) Investigating the effects of age, IQ, dosing, and anthropometric measures on the treatment persistence in long-term methylphenidate use. Nordic Journal of Psychiatry 77:4, pages 345-351.
Read now
Read now
Jeff Schein, Lenard A. Adler, Ann Childress, Martin Cloutier, Patrick Gagnon-Sanschagrin, Mikhaïl Davidson, Frédéric Kinkead, Annie Guerin & Patrick Lefebvre. (2022) Economic burden of attention-deficit/hyperactivity disorder among children and adolescents in the United States: a societal perspective. Journal of Medical Economics 25:1, pages 193-205.
Read now
Read now
Christina D. Leeth, Victor Villarreal & Kara M. Styck. (2019) Mindfulness Interventions for Children and Adolescents with ADHD: A Review of Objectives and Skills. Journal of Creativity in Mental Health 14:4, pages 436-446.
Read now
Read now
. (2019) 11th International Congress on Psychopharmacology & 7th International Symposium on Child and Adolescent Psychopharmacology. Psychiatry and Clinical Psychopharmacology 29:sup1, pages 311-446.
Read now
Read now
Shirley Shema-Shiratzky, Marina Brozgol, Pablo Cornejo-Thumm, Karen Geva-Dayan, Michael Rotstein, Yael Leitner, Jeffrey M Hausdorff & Anat Mirelman. (2019) Virtual reality training to enhance behavior and cognitive function among children with attention-deficit/hyperactivity disorder: brief report. Developmental Neurorehabilitation 22:6, pages 431-436.
Read now
Read now
Yaniv Paz, Keren Friedwald, Yeheal Levkovitz, Abraham Zangen, Uri Alyagon, Uri Nitzan, Aviv Segev, Hagai Maoz, May Koubi & Yuval Bloch. (2018) Randomised sham-controlled study of high-frequency bilateral deep transcranial magnetic stimulation (dTMS) to treat adult attention hyperactive disorder (ADHD): Negative results. The World Journal of Biological Psychiatry 19:7, pages 561-566.
Read now
Read now
Cliff Molife, Virginia S. Haynes, Allen Nyhuis, Douglas E. Faries, Steve Gelwicks, Douglas K. Kelsey & Carlos I. Alatorre. (2018) Healthcare utilization and costs of children with attention deficit/hyperactivity disorder initiating atomoxetine versus extended-release guanfacine. Current Medical Research and Opinion 34:4, pages 619-632.
Read now
Read now
Tessa Stoel, Jenny A. B. M. Houtepen, Rosalind van der Lem, Stefan Bogaerts & Jelle J. Sijtsema. (2018) Disorder-Specific Symptoms and Psychosocial Well-Being in Relation to No-Show Rates in Forensic ADHD Patients. International Journal of Forensic Mental Health 17:1, pages 61-71.
Read now
Read now
Rakesh Jain & Jeffrey G. Stark. (2016) Safety and efficacy considerations due to misuse of extended-release formulations of stimulant medications. Postgraduate Medicine 128:7, pages 672-681.
Read now
Read now
Guan-nan Bai, Yu-feng Wang, Li Yang & Wen-yi Niu. (2015) Effectiveness of a focused, brief psychoeducation program for parents of ADHD children: improvement of medication adherence and symptoms. Neuropsychiatric Disease and Treatment 11, pages 2721-2735.
Read now
Read now
Suzanne McCarthy. (2014) Pharmacological interventions for ADHD: how do adolescent and adult patient beliefs and attitudes impact treatment adherence?. Patient Preference and Adherence 8, pages 1317-1327.
Read now
Read now
David R Coghill, Tobias Banaschewski, Michel Lecendreux, César Soutullo, Alessandro Zuddas, Ben Adeyi & Shaw Sorooshian. (2014) Post hoc analyses of the impact of previous medication on the efficacy of lisdexamfetamine dimesylate in the treatment of attention-deficit/hyperactivity disorder in a randomized, controlled trial. Neuropsychiatric Disease and Treatment 10, pages 2039-2047.
Read now
Read now
Kavita Gajria, Mei Lu, Vanja Sikirica, Peter Greven, Yichen Zhong, Paige Qin & Jipan Xie. (2014) Adherence, persistence, and medication discontinuation in patients with attention-deficit/hyperactivity disorder – a systematic literature review. Neuropsychiatric Disease and Treatment 10, pages 1543-1569.
Read now
Read now
Alonso Montoya, Amaia Hervás, Joaquín Fuentes, Esther Cardo, Pepa Polavieja, Javier Quintero & Rosemary Tannock. (2014) Cluster-randomized, controlled 12-month trial to evaluate the effect of a parental psychoeducation program on medication persistence in children with attention-deficit/hyperactivity disorder. Neuropsychiatric Disease and Treatment 10, pages 1081-1092.
Read now
Read now
Lenard A. Adler, Samuel Alperin, Terry Leon & Stephen Faraone. (2014) Clinical Effects of Lisdexamfetamine and Mixed Amphetamine Salts Immediate Release in Adult ADHD: Results of a Crossover Design Clinical Trial. Postgraduate Medicine 126:5, pages 17-24.
Read now
Read now
Iris Manor, Jonathan Rubin, Yaron Daniely & Lenard A. Adler. (2014) Attention Benefits after a Single Dose of Metadoxine Extended Release in Adults with Predominantly Inattentive ADHD. Postgraduate Medicine 126:5, pages 7-16.
Read now
Read now
Carlos Roncero & F Javier Álvarez. (2014) The use of lisdexamfetamine dimesylate for the treatment of ADHD and other psychiatric disorders. Expert Review of Neurotherapeutics 14:8, pages 849-865.
Read now
Read now
Regina Bussing, Komal J. Narwaney, Almut G. Winterstein, Douglas A. Newton, Lynn DeBar, Joseph A. Boscarino, Sengwee Toh, Pamala Pawloski, James D. Nordin, Lisa J. Herrinton, Dana Mason & Matthew F. Daley. (2014) Pharmacotherapy for incident attention-deficit/hyperactivity disorder: practice patterns and quality metrics. Current Medical Research and Opinion 30:8, pages 1687-1699.
Read now
Read now
David W Goodman. (2013) Sustained treatment effect in attention-deficit/hyperactivity disorder: focus on long-term placebo-controlled randomized maintenance withdrawal and open-label studies. Therapeutics and Clinical Risk Management 9, pages 121-130.
Read now
Read now
Jihyung Hong, Diego Novick, Tamás Treuer, William Montgomery, Virginia S Haynes, Shenghu Wu & Josep Maria Haro. (2013) Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia. Patient Preference and Adherence 7, pages 987-995.
Read now
Read now
Rana Ahmed & Parisa Aslani. (2013) Attention-deficit/hyperactivity disorder: an update on medication adherence and persistence in children, adolescents and adults. Expert Review of Pharmacoeconomics & Outcomes Research 13:6, pages 791-815.
Read now
Read now
Iris Manor, Jeffrey H. Newcorn, Stephen V. Faraone & Lenard A. Adler. (2013) Efficacy of Metadoxine Extended Release in Patients With Predominantly Inattentive Subtype Attention-Deficit/Hyperactivity Disorder. Postgraduate Medicine 125:4, pages 181-190.
Read now
Read now
Adelaide Robb & Robert L. Findling. (2013) Challenges in the Transition of Care for Adolescents With Attention-Deficit/Hyperactivity Disorder. Postgraduate Medicine 125:4, pages 131-140.
Read now
Read now
Larry Culpepper & Ronna Fried. (2013) Attention-Deficit/Hyperactivity Disorder in a Chronic Care Paradigm. Postgraduate Medicine 125:4, pages 78-86.
Read now
Read now
Juliana Setyawan, Paul Hodgkins, Annie Guérin, Geneviève Gauthier, Martin Cloutier, Eric Q. Wu & M. Haim Erder. (2013) Comparing treatment adherence of lisdexamfetamine and other medications for the treatment of attention deficit/hyperactivity disorder: a retrospective analysis. Journal of Medical Economics 16:7, pages 962-975.
Read now
Read now
Ann C. Childress, F. Randy Sallee & Sally A. Berry. (2011) Single-Dose Pharmacokinetics of NWP06, an Extended-Release Methylphenidate Suspension, in Children and Adolescents with ADHD. Postgraduate Medicine 123:5, pages 80-88.
Read now
Read now
Lenard A. Adler, Lauren R. Lynch, David M. Shaw, Samantha P. Wallace, Michael A. Ciranni, Alexis M. Briggie, Agatha Kulaga, Katherine E. O'Donnell & Stephen V. Faraone. (2011) Medication Adherence and Symptom Reduction in Adults Treated with Mixed Amphetamine Salts in a Randomized Crossover Study. Postgraduate Medicine 123:5, pages 71-79.
Read now
Read now
W.
Grant Willis, LisaL. Weyandt, AnnaG. Lubiner & ChelseaD. Schubart. (2011) Neurofeedback as a Treatment for Attention-Deficit/Hyperactivity Disorder: A Systematic Review of Evidence for Practice. Journal of Applied School Psychology 27:3, pages 201-227.
Read now
Read now
Keith McBurnett & H Lynn Starr. (2011) OROS methylphenidate hydrochloride for adult patients with attention deficit/hyperactivity disorder. Expert Opinion on Pharmacotherapy 12:2, pages 315-324.
Read now
Read now
Rachel E Dew & Scott H Kollins. (2010) Lisdexamfetamine dimesylate: a new option in stimulant treatment for ADHD. Expert Opinion on Pharmacotherapy 11:17, pages 2907-2913.
Read now
Read now
Articles from other publishers (181)
Pim Ittiphakorn, Simon Erridge, Carl Holvey, Ross Coomber, James J. Rucker & Mikael H. Sodergren. (2023) UK Medical Cannabis Registry: An analysis of clinical outcomes of medicinal cannabis therapy for attention‐deficit/hyperactivity disorder. Neuropsychopharmacology Reports.
Crossref
Crossref
Olivier Corbeil, Sébastien Brodeur, Josiane Courteau, Laurent Béchard, Maxime Huot-Lavoie, Elaine Angelopoulos, Samanta Di Stefano, Erica Marrone, Alain Vanasse, Marie-Josée Fleury, Emmanuel Stip, Alain Lesage, Ridha Joober, Marie-France Demers & Marc-André Roy. (2023) Treatment with psychostimulants and atomoxetine in people with psychotic disorders: reassessing the risk of clinical deterioration in a real-world setting. The British Journal of Psychiatry, pages 1-8.
Crossref
Crossref
Timothy Wilens, Mira Stone & Thomas J. Spencer. (2023) Editorial: Height and Stimulant Treatment in Attention-Deficit/Hyperactivity Disorder Youth: Mind the Gap. Journal of the American Academy of Child & Adolescent Psychiatry 62:12, pages 1305-1307.
Crossref
Crossref
Ka-Po Wong, Bohan Zhang & Jing Qin. (2023) Unlocking Potential: The Development and User-Friendly Evaluation of a Virtual Reality Intervention for Attention-Deficit/Hyperactivity Disorder. Applied System Innovation 6:6, pages 110.
Crossref
Crossref
Ki Jin Jeun, Sabina Nduaguba & Mohammad A. Al-Mamun. (2023) Factors Influencing the Medication Adherence in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD) and Its Impact on Healthcare Utilization. Journal of Attention Disorders.
Crossref
Crossref
Gabriella D. Silverstein, Kimberly Arcoleo, Deepa Rastogi, Denise Serebrisky, Karen Warman & Jonathan M. Feldman. (2023) The Relationship Between Pediatric Attention-Deficit/Hyperactivity Disorder Symptoms and Asthma Management. Journal of Adolescent Health 73:5, pages 813-819.
Crossref
Crossref
Isabell Brikell, Honghui Yao, Lin Li, Aske Astrup, Le Gao, Malcolm B Gillies, Tian Xie, Yanli Zhang-James, Søren Dalsgaard, Anders Engeland, Stephen V Faraone, Jan Haavik, Catharina Hartman, Patrick Ip, Unnur Jakobsdóttir Smári, Henrik Larsson, Kenneth KC Man, Juliana de Oliveira Costa, Sallie-Anne Pearson, Nina Pil Hostrup Nielsen, Harold Snieder, Theresa Wimberley, Ian CK Wong, Le Zhang, Helga Zoega, Kari Klungsøyr & Zheng Chang. (2023) ADHD medication discontinuation and persistence across the lifespan: a retrospective observational study using population-based databases. The Lancet Psychiatry.
Crossref
Crossref
Lucía Caselles‐Pina, Aaron Sújar, Alejandro Quesada‐López & David Delgado‐Gómez. (2023) Adherence, frequency, and long‐term follow‐up of video game‐based treatments in patients with attention‐deficit/hyperactivity disorder: A systematic review. Brain and Behavior 13:11.
Crossref
Crossref
Duygu MURAT & Uğur TEKİN. (2023) Statistical Evaluation of Treatment Compliance In Children With Attention Deficit Hyperactivity DisorderDikkat Eksikliği Hiperaktivite Bozukluğu Olan Çocuklarda Tedavi Uyumunun İstatistiksel Değerlendirilmesi. Turkish Journal of Science and Technology 18:2, pages 535-542.
Crossref
Crossref
Yiling Song, Biyao Fan, Chunshun Wang & Hongjun Yu. (2023) Meta-analysis of the effects of physical activity on executive function in children and adolescents with attention deficit hyperactivity disorder. PLOS ONE 18:8, pages e0289732.
Crossref
Crossref
Erin McKay, Kim Cornish & Hannah Kirk. (2022) Impairments in Emotion Recognition and Positive Emotion Regulation Predict Social Difficulties in Adolescent With ADHD. Clinical Child Psychology and Psychiatry 28:3, pages 895-908.
Crossref
Crossref
Ana Checa-Ros, Antonio Muñoz-Hoyos, Antonio Molina-Carballo, Iris Viejo-Boyano, Maricarmen Chacín, Valmore Bermúdez & Luis D’Marco. (2023) Low Doses of Melatonin to Improve Sleep in Children with ADHD: An Open-Label Trial. Children 10:7, pages 1121.
Crossref
Crossref
Cecilia Lundin, Anna Wikman, Per Wikman, Helena Kopp Kallner, Inger Sundström-Poromaa & Charlotte Skoglund. (2023) Hormonal Contraceptive Use and Risk of Depression Among Young Women With Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child & Adolescent Psychiatry 62:6, pages 665-674.
Crossref
Crossref
J. F. Dixon, R. Akins, E. Miller, J. Breslau, S. Gill, E. Bisi & J. B. Schweitzer. (2022) Changing Parental Knowledge and Treatment Acceptance for ADHD: A Pilot Study. Clinical Pediatrics 62:4, pages 301-308.
Crossref
Crossref
Darian Lawrence-Sidebottom, Landry Goodgame Huffman, Jennifer Huberty, Clare Beatty, Monika Roots, Kurt Roots, Amit Parikh, Rachael Guerra & Jaclyn Weiser. (2023) Using Digital Measurement–Based Care to Address Symptoms of Inattention, Hyperactivity, and Opposition in Youth: Retrospective Analysis of Bend Health. JMIR Formative Research 7, pages e46578.
Crossref
Crossref
Michelle Ogrodnik, Sameena Karsan, Victoria Cirone & Jennifer J. Heisz. (2023) Exploring the Relationship between Cardiorespiratory Fitness and Executive Functioning in Adults with ADHD. Brain Sciences 13:4, pages 673.
Crossref
Crossref
Luiz Roberto Carvalho, Letícia M. Haas, Gregory Zeni, Marcelo M. Victor, Stefania P. Techele, Júlia Marrone Castanho, Isabel Meneghetti Coimbra, Anthony de Freitas de Sousa, Nathalia Ceretta, Alia Garrudo, Eugenio Horacio Grevet & Luis Augusto Rohde. (2023) Evaluation of the effectiveness of the FOCUS ADHD App in monitoring adults with attention-deficit/hyperactivity disorder. European Psychiatry 66:1.
Crossref
Crossref
Johnny L. Matson. 2023. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan
649
658
.
Carlin J. Miller. 2023. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan. Clinical Handbook of ADHD Assessment and Treatment Across the Lifespan
631
647
.
Astrit Vitija, Amirthan Amirthalingam & Abderrezzaq Soltani. (2022) The impact of digital interventions on medication adherence in paediatric populations with attention deficit hyperactivity disorder, depression, and/or anxiety: A rapid systematic review and meta-analysis. Research in Social and Administrative Pharmacy 18:12, pages 4017-4027.
Crossref
Crossref
Zhang Hao, Chen He, Yuan Ziqian, Liao Haotian & Li Xiaoli. (2022) Neurofeedback training for children with ADHD using individual beta rhythm. Cognitive Neurodynamics 16:6, pages 1323-1333.
Crossref
Crossref
Marcela C. Ramos, Fiona L. Macphee, Brittany M. Merrill, Amy R. Altszuler, Joseph S. Raiker, Elizabeth M. Gnagy, Andrew R. Greiner, Justin Parent, Erika K. Coles, Lisa Burger & William E. PelhamJr.Jr.. (2022) Mindfulness as an Adjunct to Behavior Modification for Elementary-aged Children with ADHD. Research on Child and Adolescent Psychopathology 50:12, pages 1573-1588.
Crossref
Crossref
Rachel M Rambler, Erica Rinehart, Wendy Boehmler, Prerna Gait, Joan Moore, Melissa Schlenker & Rahul Kashyap. (2022) A Review of the Association of Blue Food Coloring With Attention Deficit Hyperactivity Disorder Symptoms in Children. Cureus.
Crossref
Crossref
Douglas Teixeira Leffa, Eugenio Horacio Grevet, Claiton Henrique Dotto Bau, Maitê Schneider, Carolina Prietto Ferrazza, Roberta Francieli da Silva, Marina Silva Miranda, Felipe Picon, Stefania Pigatto Teche, Paulo Sanches, Danton Pereira, Katya Rubia, André Russowsky Brunoni, Joan A. Camprodon, Wolnei Caumo & Luis Augusto Rohde. (2022) Transcranial Direct Current Stimulation vs Sham for the Treatment of Inattention in Adults With Attention-Deficit/Hyperactivity Disorder. JAMA Psychiatry 79:9, pages 847.
Crossref
Crossref
Kirsty Lauder, Almuth McDowall & Harriet R. Tenenbaum. (2022) A systematic review of interventions to support adults with ADHD at work—Implications from the paucity of context-specific research for theory and practice. Frontiers in Psychology 13.
Crossref
Crossref
Rebecca Parkin, Fiona Mc Nicholas & John C. Hayden. (2022) A systematic review of interventions to enhance adherence and persistence with ADHD pharmacotherapy. Journal of Psychiatric Research 152, pages 201-218.
Crossref
Crossref
Benjamin Selaskowski, Christian Staerk, Niclas Braun, Swantje Matthies, Erika Graf, Michael Colla, Christian Jacob, Esther Sobanski, Barbara Alm, Michael Roesler, Wolfgang Retz, Petra Retz-Junginger, Bernhard Kis, Mona Abdel-Hamid, Michael Huss, Thomas Jans, Ludger Tebartz van Elst, Mathias Berger, Silke Lux, Andreas Mayr & Alexandra Philipsen. (2022) Multimodal treatment efficacy differs in dependence of core symptom profiles in adult Attention-Deficit/Hyperactivity Disorder: An analysis of the randomized controlled COMPAS trial. Journal of Psychiatric Research 151, pages 225-234.
Crossref
Crossref
Muhammad Umair Khan, Camila Balbontin, Michiel C. J. Bliemer & Parisa Aslani. (2022) Eliciting preferences for continuing medication among adult patients and parents of children with attention‐deficit hyperactivity disorder. Health Expectations 25:3, pages 1094-1107.
Crossref
Crossref
Larisa Maria Dinu, Nachaphol Phattharakulnij & Eleanor Jane Dommett. (2022) Tryptophan modulation in individuals with attention deficit hyperactivity disorder: a systematic review. Journal of Neural Transmission 129:4, pages 361-377.
Crossref
Crossref
Mónica Valero, Ausias Cebolla & Carla Colomer. (2021) Mindfulness Training for Children with ADHD and Their Parents: A Randomized Control Trial. Journal of Attention Disorders 26:5, pages 755-766.
Crossref
Crossref
K. Cedergren, S. Östlund, J. Åsberg Johnels, E. Billstedt & M. Johnson. (2021) Monitoring medication response in ADHD: what can continuous performance tests tell us?. European Archives of Psychiatry and Clinical Neuroscience 272:2, pages 291-299.
Crossref
Crossref
Kathryn Fritz & Patrick J. O'Connor. (2022) Effects of a 6 Week Yoga Intervention on Executive Functioning in Women Screening Positive for Adult ADHD: A Pilot Study. Frontiers in Sports and Active Living 4.
Crossref
Crossref
Jeff ScheinLenard A AdlerAnn ChildressPatrick Gagnon-SanschagrinMikhaïl DavidsonFrédéric KinkeadMartin CloutierAnnie GuérinPatrick Lefebvre. (2022) Economic burden of attention-deficit/hyperactivity disorder among adults in the United States: a societal perspective. Journal of Managed Care & Specialty Pharmacy 28:2, pages 168-179.
Crossref
Crossref
Lauren Amy Powell, Jack Parker, Anna Weighall & Valerie Harpin. (2021) Psychoeducation Intervention Effectiveness to Improve Social Skills in Young People with ADHD: A Meta-Analysis. Journal of Attention Disorders 26:3, pages 340-357.
Crossref
Crossref
Kairui Tang, Wenzhi Hao, Xiaowei Mo, Yueyue Chen, Xiaofang Guo, Liangliang He, Binghua Wang, Juxian Wang, Qingyu Ma, Lijuan Deng & Jiaxu Chen. (2022) Analysis of the therapeutic effect of Dimu Ningshen (TCM formula) on attention deficit hyperactivity disorder based on gut microbiota and serum metabolomics. BMC Complementary Medicine and Therapies 22:1.
Crossref
Crossref
Pei-Yin Pan, Ulf Jonsson, Sabriye Selin Şahpazoğlu Çakmak, Alexander Häge, Sarah Hohmann, Hjalmar Nobel Norrman, Jan K. Buitelaar, Tobias Banaschewski, Samuele Cortese, David Coghill & Sven Bölte. (2021) Headache in ADHD as comorbidity and a side effect of medications: a systematic review and meta-analysis. Psychological Medicine 52:1, pages 14-25.
Crossref
Crossref
Ting-Yu Chueh, Shu-Shih Hsieh, Yu-Jung Tsai, Chien-Lin Yu, Chiao-Ling Hung, Valentin Benzing, Mirko Schmidt, Yu-Kai Chang, Charles H. Hillman & Tsung-Min Hung. (2022) Effects of a single bout of moderate-to-vigorous physical activity on executive functions in children with attention-deficit/hyperactivity disorder: A systematic review and meta-analysis. Psychology of Sport and Exercise 58, pages 102097.
Crossref
Crossref
Li Shen, Chunxia Wang, Yuan Tian, Jinjin Chen, Yu Wang & Guangjun Yu. (2021) Effects of Parent-Teacher Training on Academic Performance and Parental Anxiety in School-Aged Children With Attention-Deficit/Hyperactivity Disorder: A Cluster Randomized Controlled Trial in Shanghai, China. Frontiers in Psychology 12.
Crossref
Crossref
Susan M. Bögels, Frans J. Oort, Eva Potharst, Ruud van Roosmalen, J. Mark G. Williams & Esther I. de Bruin. (2021) Family Mindfulness Training for Childhood ADHD: Short- and Long-Term Effects on Children, Fathers and Mothers. Mindfulness 12:12, pages 3011-3025.
Crossref
Crossref
Kavitha Rao, Diane M. Carpenter & Cynthia I. Campbell. (2021) Attention-Deficit/Hyperactivity Disorder Medication Adherence in the Transition to Adulthood: Associated Adverse Outcomes for Females and Other Disparities. Journal of Adolescent Health 69:5, pages 806-814.
Crossref
Crossref
Douglas Teixeira Leffa, Arthur Caye, Iná Santos, Alicia Matijasevich, Ana Menezes, Fernando C. Wehrmeister, Isabel Oliveira, Eduardo Vitola, Claiton Henrique Dotto Bau, Eugenio Horacio Grevet, Luciana Tovo-Rodrigues & Luis Augusto Rohde. (2021) Attention-deficit/hyperactivity disorder has a state-dependent association with asthma: The role of systemic inflammation in a population-based birth cohort followed from childhood to adulthood. Brain, Behavior, and Immunity 97, pages 239-249.
Crossref
Crossref
Pietro Muratori, Ciro Conversano, Valentina Levantini, Gabriele Masi, Annarita Milone, Silvia Villani, Susan Bögels & Angelo Gemignani. (2020) Exploring the Efficacy of a Mindfulness Program for Boys With Attention-Deficit Hyperactivity Disorder and Oppositional Defiant Disorder. Journal of Attention Disorders 25:11, pages 1544-1553.
Crossref
Crossref
Chi Liao. (2021) ADHD Symptoms and Financial Distress. Review of Finance 25:4, pages 1129-1210.
Crossref
Crossref
Muhammad Umair Khan & Parisa Aslani. (2020) Exploring factors influencing initiation, implementation and discontinuation of medications in adults with ADHD. Health Expectations 24:S1, pages 82-94.
Crossref
Crossref
Kiki CheungBram DierckxHanan El MarrounManon H.J. HillegersBruno H. StrickerLoes E. Visser. (2021) Methylphenidate Treatment Adherence and Persistence in Children in the Netherlands. Journal of Child and Adolescent Psychopharmacology 31:3, pages 205-213.
Crossref
Crossref
Marianne Haedener, Wolfgang Weinmann, Dominique Eich, Michael Liebrenz, Thomas Wuethrich & Anna Buadze. (2021) Evaluating the reliability of hair analysis in monitoring the compliance of ADHD patients under treatment with Lisdexamphetamine. PLOS ONE 16:3, pages e0248747.
Crossref
Crossref
Ana Checa-Ros, Antonio Jeréz-Calero, Antonio Molina-Carballo, Cristina Campoy & Antonio Muñoz-Hoyos. (2021) Current Evidence on the Role of the Gut Microbiome in ADHD Pathophysiology and Therapeutic Implications. Nutrients 13:1, pages 249.
Crossref
Crossref
Chihiro Kawai, Kenji Mori, Tetsuya Tanioka, Feni Betriana, Keiko Mori, Tatsuo Mori & Hiromichi Ito. (2021) Usefulness of Near-Infrared Spectroscopy (NIRS) for evaluating drug effects and improvements in medication adherence in children with Attention Deficit Hyperactivity Disorder (ADHD). The Journal of Medical Investigation 68:1.2, pages 53-58.
Crossref
Crossref
Lisa Jacobs & Anthony Rostain. 2021. Transition-Age Youth Mental Health Care. Transition-Age Youth Mental Health Care
237
255
.
Esther I. de Bruin, Renée Meppelink & Susan M. Bögels. 2020. Mindfulness-based Interventions with Children and Adolescents. Mindfulness-based Interventions with Children and Adolescents
74
95
.
Viktoria Johansson, Sven Sandin, Zheng Chang, Mark J. Taylor, Paul Lichtenstein, Brian M. D’Onofrio, Henrik Larsson, Clara Hellner & Linda Halldner. (2020) Medications for attention-deficit/hyperactivity disorder in individuals with or without coexisting autism spectrum disorder: analysis of data from the Swedish prescribed drug register. Journal of Neurodevelopmental Disorders 12:1.
Crossref
Crossref
Kristin N. Meyer, Rosario Santillana, Brian Miller, Wes Clapp, Marcus Way, Katrina Bridgman-Goines & Margaret A. Sheridan. (2020) Computer-based inhibitory control training in children with Attention-Deficit/Hyperactivity Disorder (ADHD): Evidence for behavioral and neural impact. PLOS ONE 15:11, pages e0241352.
Crossref
Crossref
Michelle Iznardo, Maria A. Rogers, Robert J. Volpe, Patrick R. Labelle & Philippe Robaey. (2017) The Effectiveness of Daily Behavior Report Cards for Children With ADHD: A Meta-Analysis. Journal of Attention Disorders 24:12, pages 1623-1636.
Crossref
Crossref
Joseph Biederman, Ronna Fried, Maura DiSalvo, Haley Driscoll, Allison Green, Itai Biederman, K. Yvonne Woodworth & Stephen V. Faraone. (2020) A novel digital health intervention to improve patient engagement to stimulants in adult ADHD in the primary care setting: Preliminary findings from an open label study. Psychiatry Research 291, pages 113158.
Crossref
Crossref
Henning Tiemeier. (2020) Are women using hormonal contraceptives the risk-takers?. European Journal of Epidemiology 35:9, pages 791-793.
Crossref
Crossref
Joseph Biederman, Ronna Fried, Maura DiSalvo, K. Yvonne Woodworth, Itai Biederman, Haley Driscoll, Elizabeth Noyes, Stephen V. Faraone & Roy H. Perlis. (2020) Further evidence of low adherence to stimulant treatment in adult ADHD: an electronic medical record study examining timely renewal of a stimulant prescription. Psychopharmacology 237:9, pages 2835-2843.
Crossref
Crossref
Ronna Fried, Maura DiSalvo, Caroline Kelberman, Amos Adler, Debra McCafferty, K Yvonne Woodworth, Allison Green, Itai Biederman, Stephen V Faraone & Joseph Biederman. (2020) An innovative SMS intervention to improve adherence to stimulants in children with ADHD: Preliminary findings. Journal of Psychopharmacology 34:8, pages 883-890.
Crossref
Crossref
Lucy Barnard-Brak, Brook Roberts & Evelyn Valenzuela. (2018) Examining Breaks and Resistance in Medication Adherence Among Adolescents With ADHD as Associated With School Outcomes. Journal of Attention Disorders 24:8, pages 1148-1155.
Crossref
Crossref
Erin Schoenfelder, Connor McCabe, Aurora Fife, Lisa Herzig & Kym Ahrens. (2017) Research Brief: The Teen ADHD Workshop to Improve Adolescent ADHD Treatment Engagement. Journal of Attention Disorders 24:8, pages 1192-1198.
Crossref
Crossref
Victoria Dahl, Amrita Ramakrishnan, Angela Page Spears, Annlady Jorge, Janice Lu, Nina Abraham Bigio & Anil Chacko. (2019) Psychoeducation Interventions for Parents and Teachers of Children and Adolescents with ADHD: a Systematic Review of the Literature. Journal of Developmental and Physical Disabilities 32:2, pages 257-292.
Crossref
Crossref
Muhammad Umair Khan & Parisa Aslani. (2020) A review of measures used to examine medication adherence in people with ADHD at initiation, implementation and discontinuation of pharmacotherapy. Research in Social and Administrative Pharmacy 16:3, pages 277-289.
Crossref
Crossref
Louise Foubister, Fiona Rennie & Justin Williams. (2019) Parents in Control: Parental perceptions of problem behaviors before and after attending an ADHD‐specific parent‐training program. Journal of Child and Adolescent Psychiatric Nursing 33:1, pages 30-37.
Crossref
Crossref
Jonathan Posner, Guilherme V Polanczyk & Edmund Sonuga-Barke. (2020) Attention-deficit hyperactivity disorder. The Lancet 395:10222, pages 450-462.
Crossref
Crossref
Ruchita Shah, Susanta Padhy, Adarsh Kohli & Samita Sharma. (2020) Insights from pre-treatment attrition & dropouts in an effectiveness trial of methylphenidate in children. Indian Journal of Medical Research 152:3, pages 316.
Crossref
Crossref
Manfred Döpfner, Elena Ise, Dieter Breuer, Christiane Rademacher, Tanja Wolff Metternich-Kaizman & Stephanie Schürmann. (2016) Long-Term Course After Adaptive Multimodal Treatment for Children With ADHD: An 8-Year Follow-Up. Journal of Attention Disorders 24:1, pages 145-162.
Crossref
Crossref
Friedrich Linderkamp. (2020) Die Effektivität achtsamkeitsbasierter Therapieverfahren bei Kindern und Jugendlichen mit ADHS – ein systematisches Review. Lernen und Lernstörungen 9:1, pages 25-35.
Crossref
Crossref
Kevin M. Antshel & Russell Barkley. 2020. Neurocognitive Development: Disorders and Disabilities. Neurocognitive Development: Disorders and Disabilities
37
45
.
John A. Romley, Zhiwen Xie, Tommy Chiou, Dana Goldman & Anne L. Peters. (2019) Extended-Release Formulation and Medication Adherence. Journal of General Internal Medicine 35:1, pages 354-356.
Crossref
Crossref
Anat Gesser-Edelsburg & Rasha Hamade Boukai. (2019) Does the education system serve as a persuasion agent for recommending ADHD diagnosis and medication uptake? A qualitative case study to identify and characterize the persuasion strategies of Israeli teachers and school counselors. BMC Psychiatry 19:1.
Crossref
Crossref
Yu Zang. (2019) Impact of physical exercise on children with attention deficit hyperactivity disorders. Medicine 98:46, pages e17980.
Crossref
Crossref
Michael Böttcher, David Kühne & Olof Beck. (2019) Compliance testing of patients in ADHD treatment with lisdexamphetamine (Elvanse®) using oral fluid as specimen. Clinical Mass Spectrometry 14, pages 99-105.
Crossref
Crossref
Joseph BiedermanRonna FriedMaura DiSalvoBarbara StorchAlexa PulliK. Yvonne WoodworthItai BiedermanStephen V. FaraoneRoy H. Perlis. (2019) Evidence of Low Adherence to Stimulant Medication Among Children and Youths With ADHD: An Electronic Health Records Study. Psychiatric Services 70:10, pages 874-880.
Crossref
Crossref
Kiki CheungKatia M.C. VerhammeRon HeringsLoes E. VisserBruno H. Stricker. (2019) Methylphenidate Treatment Initiated During Childhood Is Continued in Adulthood in Half of the Study Population. Journal of Child and Adolescent Psychopharmacology 29:6, pages 426-432.
Crossref
Crossref
Muhammad Umair KhanParisa Aslani. (2019) A Review of Factors Influencing the Three Phases of Medication Adherence in People with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 29:6, pages 398-418.
Crossref
Crossref
Hanife TemizsoyZeliha Özlü-ErkilicSusanne OhmannPetra Sackl-PammerChristian PopowTürkan Akkaya-Kalayci. (2019) Influence of Psychopharmacotherapy on the Quality of Life of Children with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 29:6, pages 419-425.
Crossref
Crossref
Joseph Biederman, Ronna Fried, Maura DiSalvo, K. Yvonne Woodworth, Itai Biederman, Elizabeth Noyes, Stephen V. Faraone & Roy H. Perlis. (2019) A Novel Text Message Intervention to Improve Adherence to Stimulants in Adults With Attention Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 39:4, pages 351-356.
Crossref
Crossref
Ronald SteingardSarper TaskiranDaniel F. ConnorJohn S. MarkowitzMark A. Stein. (2019) New Formulations of Stimulants: An Update for Clinicians. Journal of Child and Adolescent Psychopharmacology 29:5, pages 324-339.
Crossref
Crossref
Muhammad Umair Khan, Michael Kohn & Parisa Aslani. (2019) The need for a paradigm shift in adherence research: The case of ADHD. Research in Social and Administrative Pharmacy 15:3, pages 318-320.
Crossref
Crossref
Vitria Adisetiyo, Kevin M. Gray, Jens H. Jensen & Joseph A. Helpern. (2019) Brain iron levels in attention-deficit/hyperactivity disorder normalize as a function of psychostimulant treatment duration. NeuroImage: Clinical 24, pages 101993.
Crossref
Crossref
. 2019. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
119
.
Helena Knotkova, Ashley Clayton, Michael Stevens, Alexa Riggs, Leigh E. Charvet & Marom Bikson. 2019. Practical Guide to Transcranial Direct Current Stimulation. Practical Guide to Transcranial Direct Current Stimulation
379
405
.
Asima Zehgeer, Golda S. Ginsburg, Phyllis Lee, Boris Birmaher, John Walkup, Philip C. Kendall, Dara Sakolsky & Tara Peris. (2018) Pharmacotherapy Adherence for Pediatric Anxiety Disorders: Predictors and Relation to Child Outcomes. Child & Youth Care Forum 47:5, pages 633-644.
Crossref
Crossref
Meital Zur, Racheli Magnezi, Shirley Portuguese, Inbal Reuveni, Ron Kedem & Eyal Fruchter. (2018) The Impact of Adherence to Treatment for ADHD on the Quality of Military Service – The Israeli Military Experience. Military Medicine 183:9-10, pages e518-e524.
Crossref
Crossref
Enitan T. Marcelle, Erica J. Ho, Michelle S. Kaplan, Lenard A. Adler, F. Xavier Castellanos & Michael P. Milham. (2018) Cogmed Working Memory Training Presents Unique Implementation Challenges in Adults With ADHD. Frontiers in Psychiatry 9.
Crossref
Crossref
Ole Jakob Storebø, Nadia Pedersen, Erica Ramstad, Maja Laerke Kielsholm, Signe Sofie Nielsen, Helle B Krogh, Carlos R Moreira-Maia, Frederik L Magnusson, Mathilde Holmskov, Trine Gerner, Maria Skoog, Susanne Rosendal, Camilla Groth, Donna Gillies, Kirsten Buch Rasmussen, Dorothy Gauci, Morris Zwi, Richard Kirubakaran, Sasja J Håkonsen, Lise Aagaard, Erik Simonsen & Christian Gluud. (2018) Methylphenidate for attention deficit hyperactivity disorder (ADHD) in children and adolescents - assessment of adverse events in non-randomised studies. Cochrane Database of Systematic Reviews.
Crossref
Crossref
Diego Pablo Sánchez Martínez & José Jesús Guillén Pérez. (2018) Epidemiología del tratamiento farmacológico del trastorno por déficit de atención e hiperactividad (TDAH) en la Región de Murcia: diferencias por sexo, edad y lugar de residencia. Anales de Pediatría 88:4, pages 183-190.
Crossref
Crossref
Diego Pablo Sánchez Martínez & José Jesús Guillén Pérez. (2018) The epidemiology of pharmacologically treated attention deficit hyperactivity disorder (ADHD) in the Region of Murcia, Spain: Differences by gender, age and location of residence. Anales de Pediatría (English Edition) 88:4, pages 183-190.
Crossref
Crossref
Morgan Walls, Caitlin G. Allen, Howard Cabral, Lewis E. Kazis & Megan Bair-Merritt. (2018) Receipt of Medication and Behavioral Therapy Among a National Sample of School-Age Children Diagnosed With Attention-Deficit/Hyperactivity Disorder. Academic Pediatrics 18:3, pages 256-265.
Crossref
Crossref
Mohammed A Rashid, Sophie Lovick & Nadia R Llanwarne. (2018) Medication-taking experiences in attention deficit hyperactivity disorder: a systematic review. Family Practice 35:2, pages 142-150.
Crossref
Crossref
Alexander Häge, Lisa Weymann, Lucia Bliznak, Viktoria Märker, Konstantin Mechler & Ralf W. Dittmann. (2018) Non-adherence to Psychotropic Medication Among Adolescents – A Systematic Review of the Literature. Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 46:1, pages 69-78.
Crossref
Crossref
Anju Sawni & Kathi J. Kemper. 2018. Integrative Medicine. Integrative Medicine
53
63.e4
.
Valentin Benzing & Mirko Schmidt. (2017) Cognitively and physically demanding exergaming to improve executive functions of children with attention deficit hyperactivity disorder: a randomised clinical trial. BMC Pediatrics 17:1.
Crossref
Crossref
Andrew J. Cutler & Gregory W. Mattingly. (2017) Beyond the pill: new medication delivery options for ADHD. CNS Spectrums 22:6, pages 463-474.
Crossref
Crossref
Sevcan Karakoç Demirkaya, Hatice Aksu & Börte Gürbüz Özgür. (2017) A Retrospective Study of Long Acting Risperidone Use to Support Treatment Adherence in Youth with Conduct Disorder. Clinical Psychopharmacology and Neuroscience 15:4, pages 328-336.
Crossref
Crossref
Louis Jacob, Hajo M. Hamer & Karel Kostev. (2017) Adherence to antiepileptic drugs in children and adolescents: A retrospective study in primary care settings in Germany. Epilepsy & Behavior 75, pages 36-41.
Crossref
Crossref
Jeffrey H. Newcorn, Jeffrey G. Stark, Sherilyn Adcock, Russ McMahen & Carolyn Sikes. (2017) A Randomized Phase I Study to Assess the Effect of Alcohol on the Pharmacokinetics of an Extended-release Orally Disintegrating Tablet Formulation of Amphetamine in Healthy Adults. Clinical Therapeutics 39:8, pages 1695-1705.
Crossref
Crossref
Ying Qian, Min Chen, Lan Shuai, Qing-Jiu Cao, Li Yang & Yu-Feng Wang. (2017) Effect of an Ecological Executive Skill Training Program for School-aged Children with Attention Deficit Hyperactivity Disorder. Chinese Medical Journal 130:13, pages 1513-1520.
Crossref
Crossref
Daniel Chalk, Sean Manzi, Nicky Britten, Bettina Kluettgens, Ratidzai Magura & Jose Valderas. (2017) Can agent-based simulation be used as a tool to support polypharmacy prescribing practice?. BMJ Simulation and Technology Enhanced Learning 3:3, pages 94-98.
Crossref
Crossref
Swapna Deshpande, Britta Ostermeyer, Akshay Lokhande, Humaira Abid & Asim A. Shah. (2017) Managing Adult Attention-Deficit/Hyperactivity Disorder: To Treat or Not To Treat?. Psychiatric Annals 47:6, pages 315-321.
Crossref
Crossref
Jennifer E. Enns, Jason R. Randall, Mark Smith, Dan Chateau, Carole Taylor, Marni Brownell, James M. Bolton, Elaine Burland, Alan Katz, Laurence Y. Katz & Nathan C. Nickel. (2017) A Multimodal Intervention for Children with ADHD Reduces Inequity in Health and Education Outcomes. The Canadian Journal of Psychiatry 62:6, pages 403-412.
Crossref
Crossref
Carlos CanelaAnna BuadzeAnish DubeDominique EichMichael Liebrenz. (2017) Attitudes Toward Stimulant Treatment of Offspring of Adult Patients with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 27:5, pages 422-428.
Crossref
Crossref
Erin Schoenfelder, Megan Moreno, Molly Wilner, Kathryn B. Whitlock & Jason A. Mendoza. (2017) Piloting a mobile health intervention to increase physical activity for adolescents with ADHD. Preventive Medicine Reports 6, pages 210-213.
Crossref
Crossref
Susan dosReisAlex ParkXinyi NgEmily FroschGloria ReevesCharles CunninghamEllen M. JanssenJohn F.P. Bridges. (2017) Caregiver Treatment Preferences for Children with a New Versus Existing Attention-Deficit/Hyperactivity Disorder Diagnosis. Journal of Child and Adolescent Psychopharmacology 27:3, pages 234-242.
Crossref
Crossref
Xinyi Ng, John F. P. Bridges, Melissa M. Ross, Emily Frosch, Gloria Reeves, Charles E. Cunningham & Susan dosReis. (2016) A Latent Class Analysis to Identify Variation in Caregivers’ Preferences for their Child’s Attention-Deficit/Hyperactivity Disorder Treatment: Do Stated Preferences Match Current Treatment?. The Patient - Patient-Centered Outcomes Research 10:2, pages 251-262.
Crossref
Crossref
Vincent Chin-Hung Chen, Yao-Hsu Yang, Yin-To Liao, Ting-Yu Kuo, Hsin-Yi Liang, Kuo-You Huang, Yin-Cheng Huang, Yena Lee, Roger S. McIntyre & Tzu-Chin Lin. (2017) The association between methylphenidate treatment and the risk for fracture among young ADHD patients: A nationwide population-based study in Taiwan. PLOS ONE 12:3, pages e0173762.
Crossref
Crossref
Juliana Meyers, Kavita Gajria, Sean D Candrilli, Moshe Fridman & Vanja Sikirica. (2017) The impact of adjunctive guanfacine extended release on stimulant adherence in children/adolescents with attention-deficit/hyperactivity disorder. Journal of Comparative Effectiveness Research 6:2, pages 109-125.
Crossref
Crossref
Aliakbar Pahlevanian, Nader Alirezaloo, Sedigheh Naghel, Freshteh Alidadi, Vahid Nejati & Mohammad Kianbakht. (2015) Neurofeedback Associated with Neurocognitive-Rehabilitation Training on Children with Attention-Deficit/Hyperactivity Disorder (ADHD). International Journal of Mental Health and Addiction 15:1, pages 100-109.
Crossref
Crossref
Lidy M. Pelsser, Klaas Frankena, Jan Toorman & Rob Rodrigues Pereira. (2017) Diet and ADHD, Reviewing the Evidence: A Systematic Review of Meta-Analyses of Double-Blind Placebo-Controlled Trials Evaluating the Efficacy of Diet Interventions on the Behavior of Children with ADHD. PLOS ONE 12:1, pages e0169277.
Crossref
Crossref
Lenard A. Adler, Lauren R. Lynch, David M. Shaw, Samantha P. Wallace, Katherine E. O’Donnell, Michael A. Ciranni, Alexis M. Briggie & Stephen V. Faraone. (2016) Effectiveness and Duration of Effect of Open-Label Lisdexamfetamine Dimesylate in Adults With ADHD. Journal of Attention Disorders 21:2, pages 149-157.
Crossref
Crossref
Megan J. Cohen, Jennifer L. Curran, Thao-Ly T. Phan, Kirk Reichard & George A. Datto. (2017) Psychological contributors to noncompletion of an adolescent preoperative bariatric surgery program. Surgery for Obesity and Related Diseases 13:1, pages 58-64.
Crossref
Crossref
. 2017. Therapie psychischer Erkrankungen. Therapie psychischer Erkrankungen
1
111
.
Ann Vander Stoep, Carolyn A. McCarty, Chuan Zhou, Carol M. Rockhill, Erin N. Schoenfelder & Kathleen Myers. (2016) The Children’s Attention-Deficit Hyperactivity Disorder Telemental Health Treatment Study: Caregiver Outcomes. Journal of Abnormal Child Psychology 45:1, pages 27-43.
Crossref
Crossref
Renée Meppelink, Esther I. de Bruin & Susan M. Bögels. (2016) Meditation or Medication? Mindfulness training versus medication in the treatment of childhood ADHD: a randomized controlled trial. BMC Psychiatry 16:1.
Crossref
Crossref
David B. Clemow, Allen W. Nyhuis & Rebecca L. Robinson. (2016) Clinical Impact of Not Achieving Recommended Dose on Duration of Atomoxetine Treatment in Adults with Attention‐Deficit/Hyperactivity Disorder. CNS Neuroscience & Therapeutics 22:12, pages 970-978.
Crossref
Crossref
Laura Amado, Sonia Jarque & Roberta Ceccato. (2016) Differential impact of a multimodal versus pharmacological therapy on the core symptoms of attention deficit / hyperactivity disorder in childhood. Research in Developmental Disabilities 59, pages 93-104.
Crossref
Crossref
Kinda Ibrahim, Carsten Vogt & Parastou Donyai. (2016) Caught in the eye of the storm: a qualitative study of views and experiences of planned drug holidays from methylphenidate in child and adolescent ADHD treatment. Child and Adolescent Mental Health 21:4, pages 192-200.
Crossref
Crossref
Erin N. Schoenfelder & Tyler Sasser. (2016) Skills Versus Pills: Psychosocial Treatments for ADHD in Childhood and Adolescence. Pediatric Annals 45:10.
Crossref
Crossref
B. Bihlar Muld, J. Jokinen, S. Bölte & T. Hirvikoski. (2016) Skills training groups for men with ADHD in compulsory care due to substance use disorder: a feasibility study. ADHD Attention Deficit and Hyperactivity Disorders 8:3, pages 159-172.
Crossref
Crossref
Bengi Semerci, Sarper Taskıran, Evren Tufan & Işın Şanlı. (2016) Factors predicting treatment adherence in patients with adult attention-deficit/hyperactivity disorder: a preliminary study. ADHD Attention Deficit and Hyperactivity Disorders 8:3, pages 139-147.
Crossref
Crossref
Hanna KovshoffTobias BanaschewskiJan K. BuitelaarSara CarucciDavid CoghillMarina DanckaertsRalf W. DittmannBruno FalissardDina Gojkovic GrimshawChris HollisSarah InglisKerstin KonradElizabeth LiddleSuzanne McCarthyPeter NagyMargaret ThompsonIan C.K. WongAlessandro ZuddasEdmund J.S. Sonuga-Barke. (2016) Reports of Perceived Adverse Events of Stimulant Medication on Cognition, Motivation, and Mood: Qualitative Investigation and the Generation of Items for the Medication and Cognition Rating Scale. Journal of Child and Adolescent Psychopharmacology 26:6, pages 537-547.
Crossref
Crossref
Thomas E. Gift, Frederick W. Reimherr, Barrie K. Marchant, Tammy A. Steans & Paul H. Wender. (2016) Personality Disorder in Adult Attention-Deficit/Hyperactivity Disorder. Journal of Nervous & Mental Disease 204:5, pages 355-363.
Crossref
Crossref
Gisli H. Gudjonsson, Jon Fridrik Sigurdsson, Inga Dora Sigfusdottir, Bryndis Bjork Asgeirsdottir, Rafael A. González & Susan Young. (2015) A national epidemiological study investigating risk factors for police interrogation and false confession among juveniles and young persons. Social Psychiatry and Psychiatric Epidemiology 51:3, pages 359-367.
Crossref
Crossref
Samuele Cortese. 2016. Psychiatric Symptoms and Comorbidities in Autism Spectrum Disorder. Psychiatric Symptoms and Comorbidities in Autism Spectrum Disorder
79
91
.
James Kean, Jordy Kaufman, Justine Lomas, Antionette Goh, David White, David Simpson, Andrew Scholey, Hemant Singh, Jerome Sarris, Andrea Zangara & Con Stough. (2015) A Randomized Controlled Trial Investigating the Effects of a Special Extract of Bacopa monnieri (CDRI 08) on Hyperactivity and Inattention in Male Children and Adolescents: BACHI Study Protocol (ANZCTRN12612000827831). Nutrients 7:12, pages 9931-9945.
Crossref
Crossref
Stephen V. Faraone, Philip Asherson, Tobias Banaschewski, Joseph Biederman, Jan K. Buitelaar, Josep Antoni Ramos-Quiroga, Luis Augusto Rohde, Edmund J. S. Sonuga-Barke, Rosemary Tannock & Barbara Franke. (2015) Attention-deficit/hyperactivity disorder. Nature Reviews Disease Primers 1:1.
Crossref
Crossref
Matthew C. LambertRobert ReidBrenton ProsserRegina Bussing. (2015) A Survival Analysis of Psychostimulant Prescriptions in New South Wales from 1990 to 2010. Journal of Child and Adolescent Psychopharmacology 25:6, pages 475-481.
Crossref
Crossref
Masaharu Nagae, Hideyuki Nakane, Sumihisa Honda, Hiroki Ozawa & Hiroko Hanada. (2015) Factors Affecting Medication Adherence in Children Receiving Outpatient Pharmacotherapy and Parental Adherence. Journal of Child and Adolescent Psychiatric Nursing 28:2, pages 109-117.
Crossref
Crossref
Alexander G. FiksStephanie L. MayneLihai SongJennifer SteffesWeiwei LiuBanita McCarnBenyamin MargolisAlan GrimesEdward GotliebRussell LocalioMichelle E. RossRobert W. GrundmeierRichard WassermanLaurel K. Leslie. (2015) Changing Patterns of Alpha Agonist Medication Use in Children and Adolescents 2009–2011. Journal of Child and Adolescent Psychopharmacology 25:4, pages 362-367.
Crossref
Crossref
Saskia Schawo, Annemarie van der Kolk, Clazien Bouwmans, Lieven Annemans, Maarten Postma, Jan Buitelaar, Michel van Agthoven & Leona Hakkaart-van Roijen. (2015) Probabilistic Markov Model Estimating Cost Effectiveness of Methylphenidate Osmotic-Release Oral System Versus Immediate-Release Methylphenidate in Children and Adolescents: Which Information is Needed?. PharmacoEconomics 33:5, pages 489-509.
Crossref
Crossref
Anton Pottegård, Bine Kjøller Bjerregaard, Lisbeth Sandal Kortegaard & Helga Zoëga. (2015) Early Discontinuation of Attention-Deficit/Hyperactivity Disorder Drug Treatment: A Danish Nationwide Drug Utilization Study. Basic & Clinical Pharmacology & Toxicology 116:4, pages 349-353.
Crossref
Crossref
Samuele Cortese, Maite Ferrin, Daniel Brandeis, Jan Buitelaar, David Daley, Ralf W. Dittmann, Martin Holtmann, Paramala Santosh, Jim Stevenson, Argyris Stringaris, Alessandro Zuddas & Edmund J.S. Sonuga-Barke. (2015) Cognitive Training for Attention-Deficit/Hyperactivity Disorder: Meta-Analysis of Clinical and Neuropsychological Outcomes From Randomized Controlled Trials. Journal of the American Academy of Child & Adolescent Psychiatry 54:3, pages 164-174.
Crossref
Crossref
. 2015. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
e1
e96
.
Sven Alfonsson, Magnus Sundbom & Ata Ghaderi. (2014) Is age a better predictor of weight loss one year after gastric bypass than symptoms of disordered eating, depression, adult ADHD and alcohol consumption?. Eating Behaviors 15:4, pages 644-647.
Crossref
Crossref
Dominic Hodgkin, Constance M. Horgan, Amity E. Quinn, Elizabeth L. Merrick, Maureen T. Stewart & Laurel K. Leslie. (2014) Management of Newer Medications for Attention-Deficit/Hyperactivity Disorder in Commercial Health Plans. Clinical Therapeutics 36:12, pages 2034-2046.
Crossref
Crossref
Alexandra S. Potter, Geoffrey Schaubhut & Megan Shipman. (2014) Targeting the Nicotinic Cholinergic System to Treat Attention-Deficit/Hyperactivity Disorder: Rationale and Progress to Date. CNS Drugs 28:12, pages 1103-1113.
Crossref
Crossref
Lisa Mangle, Paula Phillips, Mark Pitts & Cathy Laver-Bradbury. (2014) Implementation of independent nurse prescribing in UK mental health settings: focus on attention-deficit/hyperactivity disorder. ADHD Attention Deficit and Hyperactivity Disorders 6:4, pages 269-279.
Crossref
Crossref
Michael J. Manos. 2015. Attention-Deficit Hyperactivity Disorder in Adults and Children. Attention-Deficit Hyperactivity Disorder in Adults and Children
353
365
.
J. Tarver, D. Daley & K. Sayal. (2014) Attention-deficit hyperactivity disorder (ADHD): an updated review of the essential facts. Child: Care, Health and Development 40:6, pages 762-774.
Crossref
Crossref
Wolfgang Retz & Petra Retz-Junginger. (2014) Prediction of methylphenidate treatment outcome in adults with attention-deficit/hyperactivity disorder (ADHD). European Archives of Psychiatry and Clinical Neuroscience 264:S1, pages 35-43.
Crossref
Crossref
Muhammed AyazAyşe Burcu AyazNusret SoyluSerhat Yüksel. (2014) Medication Persistence in Turkish Children and Adolescents with Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology 24:8, pages 442-447.
Crossref
Crossref
Edmund Sonuga-Barke, Daniel Brandeis, Martin Holtmann & Samuele Cortese. (2014) Computer-based Cognitive Training for ADHD. Child and Adolescent Psychiatric Clinics of North America 23:4, pages 807-824.
Crossref
Crossref
David Daley, Saskia van der Oord, Maite Ferrin, Marina Danckaerts, Manfred Doepfner, Samuele Cortese & Edmund J.S. Sonuga-Barke. (2014) Behavioral Interventions in Attention-Deficit/Hyperactivity Disorder: A Meta-Analysis of Randomized Controlled Trials Across Multiple Outcome Domains. Journal of the American Academy of Child & Adolescent Psychiatry 53:8, pages 835-847.e5.
Crossref
Crossref
Maite Ferrin, J. M. Moreno-Granados, M. D. Salcedo-Marin, M. Ruiz-Veguilla, V. Perez-Ayala & E. Taylor. (2013) Evaluation of a psychoeducation programme for parents of children and adolescents with ADHD: immediate and long-term effects using a blind randomized controlled trial. European Child & Adolescent Psychiatry 23:8, pages 637-647.
Crossref
Crossref
Jungeun Song, Hyun Ju Hong, Byung Ook Lee & Ki-Hwan Yook. (2014) Association of Norepinephrine Transporter Gene and Side Effects of Osmotic-Release Oral System Methylphenidate in Attention-Deficit Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 25:2, pages 82-88.
Crossref
Crossref
Bongseog Kim, Jeong-Seop Lee, Eui-Jung Kim, Hyung-Mo Sung, Yun Mi Shin, Seong-Hye Hwang & Hanik K. Yoo. (2014) Treatment Adherence of Osmotic-Controlled Release Oral Delivery System Methylphenidate in Korean Children and Adolescents with Attention-Deficit Hyperactivity Disorder. Journal of the Korean Academy of Child and Adolescent Psychiatry 25:2, pages 65-72.
Crossref
Crossref
Erin N. Schoenfelder, Stephen V. Faraone & Scott H. Kollins. (2014) Stimulant Treatment of ADHD and Cigarette Smoking: A Meta-Analysis. Pediatrics 133:6, pages 1070-1080.
Crossref
Crossref
E. Sobanski, W. Retz, R. Fischer, C. Ose, B. Alm, O. Hennig & M. Rösler. (2020) Treatment adherence and persistence in adult ADHD: Results from a twenty-four week controlled clinical trial with extended release methylphenidate. European Psychiatry 29:5, pages 324-330.
Crossref
Crossref
Robert L. Findling & Steven Dinh. (2014) Transdermal Therapy for Attention-Deficit Hyperactivity Disorder with the Methylphenidate Patch (MTS). CNS Drugs 28:3, pages 217-228.
Crossref
Crossref
Courtney A. Zulauf, Susan E. Sprich, Steven A. Safren & Timothy E. Wilens. (2014) The Complicated Relationship Between Attention Deficit/Hyperactivity Disorder and Substance Use Disorders. Current Psychiatry Reports 16:3.
Crossref
Crossref
Philip Asherson, Iris Manor & Michael Huss. (2014) Attention-deficit/hyperactivity disorder in adults: update on clinical presentation and care. Neuropsychiatry 4:1, pages 109-128.
Crossref
Crossref
Masako Nagashima, Yukifumi Monden, Ippeita Dan, Haruka Dan, Daisuke Tsuzuki, Tsutomu Mizutani, Yasushi Kyutoku, Yuji Gunji, Daisuke Hirano, Takamichi Taniguchi, Hideo Shimoizumi, Mariko Y. Momoi, Eiju Watanabe & Takanori Yamagata. (2014) Acute neuropharmacological effects of atomoxetine on inhibitory control in ADHD children: A fNIRS study. NeuroImage: Clinical 6, pages 192-201.
Crossref
Crossref
. 2014. Therapie Psychischer Erkrankungen. Therapie Psychischer Erkrankungen
1
91
.
Erin N. Schoenfelder & Scott H. Kollins. (2013) The ADHD–Smoking Comorbidity and Implications for Stimulant Treatment in Children and Adolescents. Child and Adolescent Psychopharmacology News 18:6, pages 1-5,13,14,16.
Crossref
Crossref
J J Sandra Kooij, Michael Rösler, Alexandra Philipsen, Sandra Wächter, Joachim Dejonckheere, Annemarie van der Kolk, Michel van Agthoven & Barbara Schäuble. (2013) Predictors and impact of non-adherence in adults with attention-deficit/hyperactivity disorder receiving OROS methylphenidate: results from a randomized, placebo-controlled trial. BMC Psychiatry 13:1.
Crossref
Crossref
Frank A. López & Jacques R. Leroux. (2013) Long-acting stimulants for treatment of attention-deficit/hyperactivity disorder: a focus on extended-release formulations and the prodrug lisdexamfetamine dimesylate to address continuing clinical challenges. ADHD Attention Deficit and Hyperactivity Disorders 5:3, pages 249-265.
Crossref
Crossref
Lily HechtmanMariya CherkasovaMonica MongiaTara ErringtonMilena P PondéLily Hechtman. 2013. Clinical Management of Attention Deficit Hyperactivity Disorder. Clinical Management of Attention Deficit Hyperactivity Disorder
148
160
.
Brendan SalonerCatherine FullertonThomas McGuire. (2013) The Impact of Long-Acting Medications on Attention-Deficit/Hyperactivity Disorder Treatment Disparities. Journal of Child and Adolescent Psychopharmacology 23:6, pages 401-409.
Crossref
Crossref
J. Zetterqvist, P. Asherson, L. Halldner, N. Långström & H. Larsson. (2012) Stimulant and non‐stimulant attention deficit/hyperactivity disorder drug use: total population study of trends and discontinuation patterns 2006–2009. Acta Psychiatrica Scandinavica 128:1, pages 70-77.
Crossref
Crossref
Sebastian Braun, Leo Russo, Jan Zeidler, Roland Linder & Paul Hodgkins. (2013) Descriptive Comparison of Drug Treatment–Persistent, –Nonpersistent, and Nondrug Treatment Patients With Newly Diagnosed Attention Deficit/Hyperactivity Disorder in Germany. Clinical Therapeutics 35:5, pages 673-685.
Crossref
Crossref
Paul Hammerness. 2013. ADHD in Adults. ADHD in Adults
71
87
.
Aribert Rothenberger & Lillian Geza Rothenberger. (2012) Updates on Treatment of Attention-Deficit/Hyperactivity Disorder: Facts, Comments, and Ethical Considerations. Current Treatment Options in Neurology 14:6, pages 594-607.
Crossref
Crossref
F. McNicholas. (2012) To adhere or not, and what we can do to help. European Child & Adolescent Psychiatry 21:12, pages 657-663.
Crossref
Crossref
Paul Lichtenstein, Linda Halldner, Johan Zetterqvist, Arvid Sjölander, Eva Serlachius, Seena Fazel, Niklas Långström & Henrik Larsson. (2012) Medication for Attention Deficit–Hyperactivity Disorder and Criminality. New England Journal of Medicine 367:21, pages 2006-2014.
Crossref
Crossref
Terje Torgersen, Bjørn Gjervan, Hans M. Nordahl & Kirsten Rasmussen. (2012) Predictive Factors for More Than 3 Years’ Duration of Central Stimulant Treatment in Adult Attention-Deficit/Hyperactivity Disorder. Journal of Clinical Psychopharmacology 32:5, pages 645-652.
Crossref
Crossref
Sara L. Toomey, Colin M. Sox, Donna Rusinak & Jonathan A. Finkelstein. (2012) Why Do Children With ADHD Discontinue Their Medication?. Clinical Pediatrics 51:8, pages 763-769.
Crossref
Crossref
Christina LindemannIngo LangnerAngela A. KrautTobias BanaschewskiTanja Schad-HansjostenUlrike PetermannFranz PetermannIna Schreyer-MehlhopEdeltraut GarbeRafael T. Mikolajczyk. (2012) Age-Specific Prevalence, Incidence of New Diagnoses, and Drug Treatment of Attention-Deficit/Hyperactivity Disorder in Germany. Journal of Child and Adolescent Psychopharmacology 22:4, pages 307-314.
Crossref
Crossref
Illhoi Yoo, Patricia Alafaireet, Miroslav Marinov, Keila Pena-Hernandez, Rajitha Gopidi, Jia-Fu Chang & Lei Hua. (2011) Data Mining in Healthcare and Biomedicine: A Survey of the Literature. Journal of Medical Systems 36:4, pages 2431-2448.
Crossref
Crossref
H. Caisley & U. Müller. (2020) Adherence to medication in adults with attention deficit hyperactivity disorder and pro re nata dosing of psychostimulants: A systematic review. European Psychiatry 27:5, pages 343-349.
Crossref
Crossref
Displaying 200 of 213 citing articles. Use the download link below to view the full list of citing articles.
Download full citations list